Guidelines for management of rheumatic diseases in developing countries from basics to real-world situation: relevance, need, and processes for development
- 211 Downloads
Guidelines or recommendations help to provide uniform standards in medical practice. The development of guidelines requires adherence to pre-defined norms prescribed by different international organizations such as the European League against Rheumatism (EULAR). We searched Pubmed and LILACS to identify published papers in five major rheumatic diseases (rheumatoid arthritis, systemic lupus erythematosus, spondyloarthropathies, osteoarthritis, and scleroderma) from different countries based on their economic prosperity and could find a lack of published literature from most economically weaker regions. Similarly, published guidelines in these rheumatic diseases were sparse from Asia and Africa, which are economically developed to a lesser extent than other regions of the world. Considering differing economic realities driving patient care in different regions of the world, unique challenges in certain geographic areas such as musculoskeletal manifestations of infectious diseases like leprosy and tuberculosis, as well as distinct risk of malignancies and other comorbid conditions, National Rheumatology societies should work towards developing more guidelines for rheumatic diseases from regions such as Asia and Africa, while following strictly the prescribed norms for the same. With a paucity of guidelines for such regions currently, an alternative (although less preferable) suggestion would be that major international societies, whose guidelines are widely read and followed the world over, should consider inputs from experts from diverse regions of the world while developing these guidelines.
KeywordsGuidelines Recommendations Low income Lower-middle income Developing country Rheumatology
American College of Rheumatology
Appraisal of Guidelines for Research and Evaluation
Asian Lupus Nephritis Network
Asia Pacific League against Rheumatism
Biologic disease-modifying anti-rheumatic drugs
Conventional disease-modifying anti-rheumatic drugs
European Renal Association–European Dialysis and Transplant Association
European League against Rheumatism
Grading of recommendations, assessment, development and evaluations
Gross domestic product
Gross national income
Literatura Latino Americana em Ciências da Saúde
National Institute of Clinical Excellence
Peptidyl arginine deiminase
Patient intervention comparator outcome
Preferred reporting standards for systematic reviews and meta-analysis
Protein tyrosine phosphatase 22
Standard operating procedure
World Health Organization
The conception and design of the study, or acquisition of data, or analysis and interpretation of data—DPM, AS, VA. Drafting the article—DPM; revising it critically for important intellectual content—AS, VA. Final approval of the version to be submitted—DPM, AS, VA. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved—DPM, AS, VA.
No funding was received for this study.
Compliance with ethical standards
Conflict of interest
Durga Prasanna Misra declares that he has no conflict of interest, including no relationship with pharmaceutical companies. Aman Sharma declares that he has no conflict of interest, including no relationship with pharmaceutical companies. Vikas Agarwal declares that he has no conflict of interest, including no relationship with pharmaceutical companies.
This article does not contain any studies with human participants or animals performed by any of the authors.
- 5.Cam KM, McKnight PE, Doctor JN (2002) The delphi method online: medical expert consensus via the internet. In: Proceedings of the AMIA symposium, pp. 990Google Scholar
- 6.WHO (2014) Handbook for guideline development 2nd Edition [Internet] http://apps.who.int/medicinedocs/documents/s22083en/s22083en.pdf. Accessed 21 Dec 2017
- 7.Developing NICE guidelines [Internet] https://www.nice.org.uk/process/pmg20/chapter/introduction-and-overview. Accessed on 21 Dec 2017
- 8.PRISMA Checklist [Internet] http://www.prisma-statement.org/documents/PRISMA2009checklist.doc. Accessed 6 Dec 2017
- 10.GRADEpro [Internet] http://gdt.guidelinedevelopment.org/app/handbook/handbook.html. Accessed 21 Nov 2017
- 12.World Bank Country and Lending Groups [Internet] https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups. Accessed 18 Dec 2017
- 13.Public health expenditure (percentage of GDP) [Internet] https://data.worldbank.org/indicator/SH.XPD.PUBL.ZS Accessed 21 Dec 2017
- 14.World population by continent [Internet] http://worldpopulationreview.com/continents/. Accessed 23 Dec 2017
- 15.NHS UK [Internet] https://www.nhs.uk/NHSEngland/thenhs/about/Pages/overview.aspx Accessed 23 Dec 2017
- 16.Healthcare in India [Internet] http://assets.ce.columbia.edu/pdf/actu/actu-india.pdf. Accessed 23 Dec 2017
- 24.Bertsias GK, Tektonidou M, Amoura Z et al (2012) Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis 71:1771–1782. https://doi.org/10.1136/annrheumdis-2012-201940 CrossRefPubMedPubMedCentralGoogle Scholar